Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001140361-26-028114
Filing Date
2026-07-09
Accepted
2026-07-09 16:30:19
Documents
3

Document Format Files

Seq Description Document Type Size
1 424B3 ny20076831x3_424b3.htm 424B3 185477
2 logo_aquestive.jpg GRAPHIC 26566
3 logo_aquestivex1.jpg GRAPHIC 43976
  Complete submission text file 0001140361-26-028114.txt   283384
Mailing Address 30 TECHNOLOGY DRIVE WARREN NJ 07059
Business Address 30 TECHNOLOGY DRIVE WARREN NJ 07059 908-941-1900
Aquestive Therapeutics, Inc. (Filer) CIK: 0001398733 (see all company filings)

EIN.: 208623253 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-297069 | Film No.: 261166020
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)